Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)

Blood (2024) 144 (Supplement 1): 3516.

https://doi.org/10.1182/blood-2024-205130

Published: 2024

Journal Articles

High-Frequency Temperature Monitoring Detects Clinically Actionable Fevers Otherwise Missed By Standard-of-Care Monitoring during Treatment of Hematologic Malignancies

Shihan N. Khan, Muneesh Tewari, Seungwoo Lee, Christopher Flora, Rashmi Madhukar, Kelly Mayhew, Michelle Rozwadowski, Kay Leopold, Jason B. Weinberg, Thomas Braun, Monalisa Ghosh, David Frame, Sung W. Choi

Blood (2024) 144 (Supplement 1): 7500.

https://doi.org/10.1182/blood-2024-194678

Published: 2024

Journal Articles

Proteomics Analysis Identifies Candidate Biomarkers for Prediction of Post-CAR-T Cytopenias

Rashmi Madhukar, Christopher Flora, Mary Olesnavich, Erin Sandford, Michelle Rozwadowski, Gen Li, Marcus Johannes Geer, Gregory Yanik, Monalisa Ghosh, David Frame, Jennifer Elise Agrusa, Challice L. Bonifant, Tania Jain, Sung W. Choi, Muneesh Tewari

Blood (2024) 144 (Supplement 1): 7168.

https://doi.org/10.1182/blood-2024-211453

Published: 2024

Journal Articles

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study

Mary Mansour Riwes, Jonathan Louis Golob, John M. Magenau, Costas Lyssiotis, Mengrou Shan, Gregory Dick, Thomas Braun, Thomas M Schmidt, Attaphol Pawarode, Sarah Anand, Monalisa Ghosh, John Maciejewski, Darren King, Sung W. Choi, Gregory Yanik, Marcus Johannes Geer, Ethan Hillman, Muneesh Tewari, Pavan Reddy

Blood (2023) 142 (Supplement 1): 2190.

https://doi.org/10.1182/blood-2023-181260

Published: 2023

Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Blood (2023) 142 (Supplement 1): 475.

https://doi.org/10.1182/blood-2023-188032

Published: 2023

Journal Articles

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events

Blood (2023) 142 (8): 700–710.

https://doi.org/10.1182/blood.2023020035

Published: 2023

Includes: Supplemental data

Journal Articles

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Monzr M. Al Malki, Steven M Devine, Bronwen E. Shaw, Larisa Broglie, Muna Qayed, Sung W. Choi, Stephen R. Spellman, Craig Malmberg, Eric Ndifon, Brent Logan, Jeffery Auletta, Heather E Stefanski, Janelle A. Olson, Antonio Jimenez Jimenez

Blood (2022) 140 (Supplement 1): 7591–7593.

https://doi.org/10.1182/blood-2022-162581

Published: 2022

Journal Articles

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139031

Published: 2020

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

Mahasweta Gooptu, MD, Haesook T. Kim, PhD, Alan Howard, PhD, Sung W. Choi, MD MS, Robert J. Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD PhD, Corey S. Cutler, MD MPH

Blood (2018) 132 (Supplement 1): 2110.

https://doi.org/10.1182/blood-2018-99-115662

Published: 2018

Journal Articles

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Blood (2017) 130 (Supplement 1): 212.

https://doi.org/10.1182/blood.V130.Suppl_1.212.212

Published: 2017

Journal Articles

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

Mark T. Vander Lugt, M.D., Thomas M. Braun, Ph.D., Samir Hanash, M.D., Ph.D., James L.M. Ferrara, MD, DSc, Jerome Ritz, MD, Vincent T. Ho, MD, Joseph H. Antin, MD, Qing Zhang, Alice Chin, Aurelie Gomez, MD, Andrew C. Harris, M.D., John E. Levine, M.D., M.S., Sung W. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, M.D., Ph.D

Blood (2012) 120 (21): 466.

https://doi.org/10.1182/blood.V120.21.466.466

Published: 2012

Journal Articles

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Thomas M. Braun, Ph.D., Daniel R. Couriel, M.D., Sung W. Choi, M.D., Carrie Kitko, M.D., Steven Goldstein, John M. Magenau, M.D., Sophie Paczesny, M.D., Ph.D, Attaphol Pawarode, Pavan Reddy, M.D., Gregory A. Yanik, Austin Taylor, James Connelly, M.D., Craig A. Byersdorfer, M.D., Ph.D., John E. Levine, M.D., M.S.

Blood (2012) 120 (21): 463.

https://doi.org/10.1182/blood.V120.21.463.463

Published: 2012

Journal Articles

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

Corey Cutler, MD, MPH, FRCPC, Brent R. Logan, PhD, Ryotaro Nakamura, MD, Laura Johnston, MD, Sung W. Choi, M.D., David L Porter, MD, William J Hogan, MBBCh, Marcelo C Pasquini, MD, MS, Margaret L. MacMillan, MD, John R. Wingard, MD, Edmund K. Waller, MD, PhD, Stephan A. Grupp, MD, PhD, Philip L. McCarthy, MD, Juan Wu, MS, Zhenhuan Hu, MPH, Shelly L Carter, ScD, Mary M. Horowitz, MD, MS, Joseph H. Antin, MD

Blood (2012) 120 (21): 739.

https://doi.org/10.1182/blood.V120.21.739.739

Published: 2012

Journal Articles

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Carrie L Kitko, Rima M Saliba, PhD, Sophie Paczesny, MD, PhD., Maggi Kennel, BS, MS, Sung W. Choi, M.D., Pavan Reddy, M.D., John E. Levine, M.D., M.S., Daniel R. Couriel, M.D.

Blood (2012) 120 (21): 1941.

https://doi.org/10.1182/blood.V120.21.1941.1941

Published: 2012

Journal Articles

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Blood (2012) 120 (21): 740.

https://doi.org/10.1182/blood.V120.21.740.740

Published: 2012

Journal Articles

Plasma biomarkers of lower gastrointestinal and liver acute GVHD

Andrew C. Harris, James L. M. Ferrara, Thomas M. Braun, Ernst Holler, Takanori Teshima, John E. Levine, Sung W. Choi, Karin Landfried, Koichi Akashi, Mark Vander Lugt, Daniel R. Couriel, Pavan Reddy, Sophie Paczesny

Blood (2012) 119 (12): 2960–2963.

https://doi.org/10.1182/blood-2011-10-387357

Published: 2012

Includes: Supplemental data

Journal Articles

Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

John M. Magenau, MD, Xuemei Qin, MD, Isao Tawara, MD, PhD, Clare E Rogers, MS, Matthew Schlough, Daniel Bickley, Pil Sang Jang, MD, Thomas M Braun, PhD, Kathleen Lowler, Dawn M Jones, RN, Sung W Choi, MD, Shin Mineishi, MD, John E. Levine, MD, James LM Ferrara, MD, DSc, Sophie Paczesny, MD, PhD

Blood (2009) 114 (22): 514.

https://doi.org/10.1182/blood.V114.22.514.514

Published: 2009

Journal Articles

A biomarker panel for acute graft-versus-host disease

Sophie Paczesny, Oleg I. Krijanovski, Thomas M. Braun, Sung W. Choi, Shawn G. Clouthier, Rork Kuick, David E. Misek, Kenneth R. Cooke, Carrie L. Kitko, Angela Weyand, Daniel Bickley, Dawn Jones, Joel Whitfield, Pavan Reddy, John E. Levine, Samir M. Hanash, James L. M. Ferrara

Blood (2009) 113 (2): 273–278.

https://doi.org/10.1182/blood-2008-07-167098

Published: 2009

Includes: Supplemental data

Journal Articles

Implementation of Computerized Provider Order Entry (CPOE) Does Not Impact Provider Work Time in An Inpatient Malignant Hematology Service

David A Hanauer, MD, MS, Sung W Choi, MD, Robert W Beasley, Ronald B Hirschl, MD, Douglas W Blayney, MD

Blood (2008) 112 (11): 4704.

https://doi.org/10.1182/blood.V112.11.4704.4704

Published: 2008

NARROW

Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)

High-Frequency Temperature Monitoring Detects Clinically Actionable Fevers Otherwise Missed By Standard-of-Care Monitoring during Treatment of Hematologic Malignancies

Proteomics Analysis Identifies Candidate Biomarkers for Prediction of Post-CAR-T Cytopenias

Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402)

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Plasma biomarkers of lower gastrointestinal and liver acute GVHD

Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

A biomarker panel for acute graft-versus-host disease

Implementation of Computerized Provider Order Entry (CPOE) Does Not Impact Provider Work Time in An Inpatient Malignant Hematology Service

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only